Your browser doesn't support javascript.
loading
Combined therapy of prednisone and mTOR inhibitor sirolimus for treating retroperitoneal fibrosis.
Gao, Hui; Liu, Shibo; Mai, Yuanbang; Wang, Yuying; Zhang, Xuewu; Zheng, Shufen; Luo, Chenghua; Pan, Cuiping.
Afiliación
  • Gao H; Department of Rheumatology and Immunology, Peking University International Hospital, Beijing, China.
  • Liu S; Department of Retroperitoneal Tumor Surgery, Peking University International Hospital, Beijing, China.
  • Mai Y; Center for Intelligent Medicine Research, Greater Bay Area Institute of Precision Medicine (Guangzhou), Fudan University, Guangzhou, China.
  • Wang Y; School of Life Sciences, Fudan University, Shanghai, China.
  • Zhang X; Department of Pharmacy, Peking University International Hospital, Beijing, China.
  • Zheng S; Department of Rheumatology, Peking University People's Hospital, Beijing, China.
  • Luo C; Center for Intelligent Medicine Research, Greater Bay Area Institute of Precision Medicine (Guangzhou), Fudan University, Guangzhou, China.
  • Pan C; School of Life Sciences, Fudan University, Shanghai, China.
Ann Rheum Dis ; 82(5): 688-697, 2023 05.
Article en En | MEDLINE | ID: mdl-36720581
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fibrosis Retroperitoneal Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Ann Rheum Dis Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fibrosis Retroperitoneal Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: Ann Rheum Dis Año: 2023 Tipo del documento: Article País de afiliación: China